A Meta-Analysis on Randomised Controlled Clinical Trials Evaluating the Effect of the Dietary Supplement Chitosan on Weight Loss, Lipid Parameters and Blood Pressure
Background and objectives: Erratic results have been published concerning the influence of the dietary supplement chitosan used as a complementary remedy to decrease the body weight of overweight and obese people. The published articles mention as secondary possible benefits of usage of chitosan the...
Saved in:
| Published in: | Medicina (Kaunas, Lithuania) Vol. 54; no. 6; p. 109 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Switzerland
MDPI
12.12.2018
MDPI AG |
| Subjects: | |
| ISSN: | 1648-9144, 1010-660X, 1648-9144, 1010-660X |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background and objectives: Erratic results have been published concerning the influence of the dietary supplement chitosan used as a complementary remedy to decrease the body weight of overweight and obese people. The published articles mention as secondary possible benefits of usage of chitosan the improvement of blood pressure and serum lipids status. We performed a meta-analysis evaluating body weight, body mass index, total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, systolic and diastolic blood pressure among overweight and obese patients. Materials and Methods: Searching MEDLINE, Cochrane up to December 2017 on clinical trials that have assessed the influence of chitosan used as a dietary supplement on overweight and obese patients. An additional study was identified in the References section of another meta-analysis. A total of 14 randomised control trials (RCT) were used to assess the effect on body weight, serum lipids and blood pressure. Results: The usage of chitosan as a dietary supplement up to 52 weeks seems to slightly reduce the body weight (−1.01 kg, 95% CI: −1.67 to −0.34). Considering the other parameters studied, the most significant improvement was observed in systolic and diastolic blood pressure: −2.68 mm Hg (95% CI: −4.19 to −1.18) and −2.14 mm Hg (95% CI: −4.14 to −0.14) in favour of chitosan versus a placebo. Conclusions: Based on the meta-analysis realized with 14 RCT we concluded that the usage of chitosan as a dietary supplement can lead to a slight short- and medium-term effect on weight loss and to the improvement of serum lipid profile and cardiovascular factors. |
|---|---|
| AbstractList | Background and objectives: Erratic results have been published concerning the influence of the dietary supplement chitosan used as a complementary remedy to decrease the body weight of overweight and obese people. The published articles mention as secondary possible benefits of usage of chitosan the improvement of blood pressure and serum lipids status. We performed a meta-analysis evaluating body weight, body mass index, total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, systolic and diastolic blood pressure among overweight and obese patients. Materials and Methods: Searching MEDLINE, Cochrane up to December 2017 on clinical trials that have assessed the influence of chitosan used as a dietary supplement on overweight and obese patients. An additional study was identified in the References section of another meta-analysis. A total of 14 randomised control trials (RCT) were used to assess the effect on body weight, serum lipids and blood pressure. Results: The usage of chitosan as a dietary supplement up to 52 weeks seems to slightly reduce the body weight (-1.01 kg, 95% CI: -1.67 to -0.34). Considering the other parameters studied, the most significant improvement was observed in systolic and diastolic blood pressure: -2.68 mm Hg (95% CI: -4.19 to -1.18) and -2.14 mm Hg (95% CI: -4.14 to -0.14) in favour of chitosan versus a placebo. Conclusions: Based on the meta-analysis realized with 14 RCT we concluded that the usage of chitosan as a dietary supplement can lead to a slight short- and medium-term effect on weight loss and to the improvement of serum lipid profile and cardiovascular factors.Background and objectives: Erratic results have been published concerning the influence of the dietary supplement chitosan used as a complementary remedy to decrease the body weight of overweight and obese people. The published articles mention as secondary possible benefits of usage of chitosan the improvement of blood pressure and serum lipids status. We performed a meta-analysis evaluating body weight, body mass index, total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, systolic and diastolic blood pressure among overweight and obese patients. Materials and Methods: Searching MEDLINE, Cochrane up to December 2017 on clinical trials that have assessed the influence of chitosan used as a dietary supplement on overweight and obese patients. An additional study was identified in the References section of another meta-analysis. A total of 14 randomised control trials (RCT) were used to assess the effect on body weight, serum lipids and blood pressure. Results: The usage of chitosan as a dietary supplement up to 52 weeks seems to slightly reduce the body weight (-1.01 kg, 95% CI: -1.67 to -0.34). Considering the other parameters studied, the most significant improvement was observed in systolic and diastolic blood pressure: -2.68 mm Hg (95% CI: -4.19 to -1.18) and -2.14 mm Hg (95% CI: -4.14 to -0.14) in favour of chitosan versus a placebo. Conclusions: Based on the meta-analysis realized with 14 RCT we concluded that the usage of chitosan as a dietary supplement can lead to a slight short- and medium-term effect on weight loss and to the improvement of serum lipid profile and cardiovascular factors. Background and objectives: Erratic results have been published concerning the influence of the dietary supplement chitosan used as a complementary remedy to decrease the body weight of overweight and obese people. The published articles mention as secondary possible benefits of usage of chitosan the improvement of blood pressure and serum lipids status. We performed a meta-analysis evaluating body weight, body mass index, total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, systolic and diastolic blood pressure among overweight and obese patients. Materials and Methods: Searching MEDLINE, Cochrane up to December 2017 on clinical trials that have assessed the influence of chitosan used as a dietary supplement on overweight and obese patients. An additional study was identified in the References section of another meta-analysis. A total of 14 randomised control trials (RCT) were used to assess the effect on body weight, serum lipids and blood pressure. Results: The usage of chitosan as a dietary supplement up to 52 weeks seems to slightly reduce the body weight (−1.01 kg, 95% CI: −1.67 to −0.34). Considering the other parameters studied, the most significant improvement was observed in systolic and diastolic blood pressure: −2.68 mm Hg (95% CI: −4.19 to −1.18) and −2.14 mm Hg (95% CI: −4.14 to −0.14) in favour of chitosan versus a placebo. Conclusions: Based on the meta-analysis realized with 14 RCT we concluded that the usage of chitosan as a dietary supplement can lead to a slight short- and medium-term effect on weight loss and to the improvement of serum lipid profile and cardiovascular factors. Erratic results have been published concerning the influence of the dietary supplement chitosan used as a complementary remedy to decrease the body weight of overweight and obese people. The published articles mention as secondary possible benefits of usage of chitosan the improvement of blood pressure and serum lipids status. We performed a meta-analysis evaluating body weight, body mass index, total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, systolic and diastolic blood pressure among overweight and obese patients. Searching MEDLINE, Cochrane up to December 2017 on clinical trials that have assessed the influence of chitosan used as a dietary supplement on overweight and obese patients. An additional study was identified in the References section of another meta-analysis. A total of 14 randomised control trials (RCT) were used to assess the effect on body weight, serum lipids and blood pressure. The usage of chitosan as a dietary supplement up to 52 weeks seems to slightly reduce the body weight (-1.01 kg, 95% CI: -1.67 to -0.34). Considering the other parameters studied, the most significant improvement was observed in systolic and diastolic blood pressure: -2.68 mm Hg (95% CI: -4.19 to -1.18) and -2.14 mm Hg (95% CI: -4.14 to -0.14) in favour of chitosan versus a placebo. Based on the meta-analysis realized with 14 RCT we concluded that the usage of chitosan as a dietary supplement can lead to a slight short- and medium-term effect on weight loss and to the improvement of serum lipid profile and cardiovascular factors. |
| Author | Ostafe, Vasile Timar, Bogdan Frandes, Mirela Moraru, Cristina Mincea, Manuela Maria |
| AuthorAffiliation | 1 Department of Biology-Chemistry, Advanced Environmental Research Laboratory, West University of Timisoara, Timisoara 300086, Romania; cristina.g.moraru@gmail.com (C.M.); manuelamincea@yahoo.com (M.M.M.) 2 Department of Biostatistics and Medical Informatics, “Victor Babes” University of Medicine and Pharmacy, Timisoara 300041, Romania; mirela.frandes@umft.ro (M.F.); timar.bogdan@umft.ro (B.T.) |
| AuthorAffiliation_xml | – name: 2 Department of Biostatistics and Medical Informatics, “Victor Babes” University of Medicine and Pharmacy, Timisoara 300041, Romania; mirela.frandes@umft.ro (M.F.); timar.bogdan@umft.ro (B.T.) – name: 1 Department of Biology-Chemistry, Advanced Environmental Research Laboratory, West University of Timisoara, Timisoara 300086, Romania; cristina.g.moraru@gmail.com (C.M.); manuelamincea@yahoo.com (M.M.M.) |
| Author_xml | – sequence: 1 givenname: Cristina surname: Moraru fullname: Moraru, Cristina – sequence: 2 givenname: Manuela Maria surname: Mincea fullname: Mincea, Manuela Maria – sequence: 3 givenname: Mirela orcidid: 0000-0002-5249-6859 surname: Frandes fullname: Frandes, Mirela – sequence: 4 givenname: Bogdan surname: Timar fullname: Timar, Bogdan – sequence: 5 givenname: Vasile surname: Ostafe fullname: Ostafe, Vasile |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30545156$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kk1vEzEQhleoiH7AnRPykQMBe9f27l6QSghQKQgERRytWXs2ceXYqe2t1B_E_8RpWtRW4uTxeOZ55XnnuDrwwWNVvWT0bdP09N0GjdXWg-BUUkb7J9URk7yb9Yzzg3vxYXWc0gWlTS3a-ll12FDBBRPyqPpzSr5ihtmpB3edbCLBkx_gTdjYhIbMg88xOLcLnfVWgyPn0YJLZHEFboJs_YrkNZLFOKLOJIw3t4-2QOM1-Tlttw436DOZr20OCfxO4Tfa1TqTZUjpDVnarTXkO0TYYMaYSJEnH1wIJRkxpSni8-rpWDTxxe15Uv36tDiff5ktv30-m58uZ5rLOs9012iUHQy07qgRox4HzSkzQ81HTTs0AxqqKQXO-tFgK1rWoOB1q6E2tTbNSXW255oAF2ob7aZ8QgWw6iYR4kpBzFY7VKaXbSMNZ3JHN6LHGoeOC6kpgK51Yb3fs7bTUHzSZQYR3APowxdv12oVrpRsqOxFUwCvbwExXE6YsiqeaHQOPIYpqZqJVrai410pfXVf65_Inc-lQO4LdCwzjzgqbXMxb2cvWKcYVbuFUo8XqjTSR4137P-2_AXgvdQi |
| CitedBy_id | crossref_primary_10_1080_10408398_2023_2178379 crossref_primary_10_1186_s13098_023_01037_6 crossref_primary_10_3390_ijms242015270 crossref_primary_10_1002_fsat_3602_5_x crossref_primary_10_3390_ijerph18178897 crossref_primary_10_3390_md20120784 crossref_primary_10_3390_md18110557 crossref_primary_10_3390_molecules30051017 crossref_primary_10_1177_2515690X211043738 crossref_primary_10_1021_acs_biomac_4c01682 crossref_primary_10_3390_nu12092873 crossref_primary_10_52711_0974_360X_2024_00219 crossref_primary_10_1186_s12887_022_03590_x crossref_primary_10_1016_j_carbpol_2021_118999 crossref_primary_10_26599_FMH_2025_9420061 crossref_primary_10_3390_molecules28041963 crossref_primary_10_3390_pharmaceutics16121556 crossref_primary_10_3390_molecules30061297 crossref_primary_10_3390_nu12082365 crossref_primary_10_1016_j_tifs_2021_03_059 crossref_primary_10_3390_ma18102178 crossref_primary_10_1016_j_advnut_2023_09_011 crossref_primary_10_1007_s44187_025_00433_3 crossref_primary_10_1002_app_50841 crossref_primary_10_3390_nu12071960 crossref_primary_10_1186_s12937_020_00647_4 crossref_primary_10_1186_s41043_025_00797_3 crossref_primary_10_1146_annurev_food_070720_112725 crossref_primary_10_3390_jcm12103414 |
| Cites_doi | 10.5604/17322693.1135416 10.1038/sj.ejcn.1601603 10.1016/B978-0-08-045316-3.00025-9 10.1186/1471-2458-8-200 10.1080/07315724.2002.10719246 10.20944/preprints201801.0046.v2 10.1038/sj.ijo.0802693 10.1016/S0140-6736(15)60163-5 10.1186/s40608-015-0053-5 10.1089/109662003772519985 10.1002/jsfa.8301 10.3390/nu5041218 10.2903/j.efsa.2011.2214 10.1016/j.nutres.2010.06.005 10.1016/S0011-393X(03)00058-4 10.1161/JAHA.115.002713 10.1038/sj.ejcn.1600733 10.2337/diacare.23.11.1703a 10.1001/jama.289.2.187 10.1503/cmaj.140887 10.1111/j.1467-789X.2005.00158.x 10.1111/j.1742-7843.2005.pto_111.x 10.3310/hta13410 10.1186/s12937-016-0122-8 10.2337/diacare.20.4.614 10.1201/EBK1439816035 10.3945/cdn.117.000919 10.1055/s-2002-32040 10.1080/07315724.2006.10719550 10.1016/S0140-6736(14)60460-8 10.5455/msm.2012.24.87-90 10.1371/journal.pmed.1000097 10.5009/gnl15125 10.1007/s11892-009-0055-0 |
| ContentType | Journal Article |
| Copyright | 2018 by the authors. 2018 |
| Copyright_xml | – notice: 2018 by the authors. 2018 |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.3390/medicina54060109 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1648-9144 1010-660X |
| ExternalDocumentID | oai_doaj_org_article_d96736d416b24fd59e2eb8456c0aac2c PMC6306953 30545156 10_3390_medicina54060109 |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii grantid: 14/2017, PNIII-P3-285 |
| GroupedDBID | 0R~ 29M 2WC 4.4 457 53G 5GY 5VS 7X7 8FI 8FJ AADQD AAEDT AAFWJ AAIKJ AAYXX ABMAC ABUWG ACGFS ADBBV ADEZE AFFHD AFKRA AFPKN AFZYC AGHFR AHDRD ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU CITATION F5P FDB FYUFA GROUPED_DOAJ HMCUK HYE IAO IHR KQ8 MODMG O9- OK1 OVT PGMZT PHGZM PHGZT PIMPY RPM UKHRP XSB ALIPV NPM RIG 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c462t-c83ce68ab0280d5fcfbc401db24fc08edbed0c00a419fde75713e5427ca2d2cd3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 33 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000455621300018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1648-9144 1010-660X |
| IngestDate | Fri Oct 03 12:37:06 EDT 2025 Tue Nov 04 01:52:05 EST 2025 Fri Sep 05 06:45:48 EDT 2025 Mon Jul 21 05:42:39 EDT 2025 Sat Nov 29 07:15:53 EST 2025 Tue Nov 18 21:29:02 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | body weight meta-analysis blood pressure chitosan overweight and obese patients serum lipids |
| Language | English |
| License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c462t-c83ce68ab0280d5fcfbc401db24fc08edbed0c00a419fde75713e5427ca2d2cd3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-5249-6859 |
| OpenAccessLink | https://doaj.org/article/d96736d416b24fd59e2eb8456c0aac2c |
| PMID | 30545156 |
| PQID | 2157675848 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_d96736d416b24fd59e2eb8456c0aac2c pubmedcentral_primary_oai_pubmedcentral_nih_gov_6306953 proquest_miscellaneous_2157675848 pubmed_primary_30545156 crossref_citationtrail_10_3390_medicina54060109 crossref_primary_10_3390_medicina54060109 |
| PublicationCentury | 2000 |
| PublicationDate | 20181212 |
| PublicationDateYYYYMMDD | 2018-12-12 |
| PublicationDate_xml | – month: 12 year: 2018 text: 20181212 day: 12 |
| PublicationDecade | 2010 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Medicina (Kaunas, Lithuania) |
| PublicationTitleAlternate | Medicina (Kaunas) |
| PublicationYear | 2018 |
| Publisher | MDPI MDPI AG |
| Publisher_xml | – name: MDPI – name: MDPI AG |
| References | Glass (ref_36) 1977; 5 Ylitalo (ref_28) 2002; 52 Veneroni (ref_46) 1996; 17 Knight (ref_1) 2011; 41 Ho (ref_41) 2001; 42 Khaodhiar (ref_5) 2009; 9 Sicinska (ref_17) 2015; 69 Colombo (ref_44) 1996; 17 ref_19 Pittler (ref_23) 1999; 53 Serban (ref_16) 2016; 5 Macchi (ref_54) 1996; 17 Bokura (ref_26) 2003; 57 ref_22 Willers (ref_6) 2012; 2 ref_20 Giustina (ref_45) 1995; 16 Allaert (ref_25) 2017; 65 Kaats (ref_39) 2006; 25 Lehtimaki (ref_24) 2005; 97 ref_27 Cornelli (ref_42) 2017; 1 Ng (ref_13) 2014; 384 (ref_32) 2010; 30 Mhurchu (ref_48) 2005; 6 ref_35 Ausar (ref_51) 2003; 6 Sciutto (ref_55) 1995; 16 ref_30 Poppitt (ref_37) 2004; 28 Guha (ref_53) 2005; 103 Brauer (ref_14) 2015; 187 Cornelli (ref_29) 2008; 56 Woodgate (ref_40) 2003; 64 Schiller (ref_38) 2001; 4 Klop (ref_3) 2013; 5 Kim (ref_15) 2015; 9 Akter (ref_4) 2017; 26 Trivedi (ref_31) 2016; 15 Picot (ref_11) 2009; 13 Tai (ref_52) 2000; 23 Fontaine (ref_10) 2003; 289 Gerstein (ref_50) 2002; 2 ref_43 Ernst (ref_47) 1998; 11 Pyorala (ref_49) 1997; 20 Gallaher (ref_21) 2002; 21 ref_9 ref_8 Kleinert (ref_12) 2015; 385 Santas (ref_33) 2017; 97 Rinaudo (ref_18) 2007; 38 Praso (ref_2) 2012; 24 Jull (ref_34) 2008; 3 ref_7 |
| References_xml | – volume: 26 start-page: 7 year: 2017 ident: ref_4 article-title: Effect of Obesity on Fasting Blood Sugar publication-title: Mymensingh Med. J. – ident: ref_9 – volume: 69 start-page: 25 year: 2015 ident: ref_17 article-title: The use of various diet supplements in metabolic syndrome publication-title: Postepy Higieny i Medycyny Doswiadczalnej doi: 10.5604/17322693.1135416 – volume: 57 start-page: 721 year: 2003 ident: ref_26 article-title: Chitosan decreases total cholesterol in women: A randomized, double-blind, placebo-controlled trial publication-title: Eur. J. Clin. Nutr. doi: 10.1038/sj.ejcn.1601603 – ident: ref_19 doi: 10.1016/B978-0-08-045316-3.00025-9 – volume: 17 start-page: 278 year: 1996 ident: ref_44 article-title: Nutritional aspects of chitosan employment in hypocaloric diet publication-title: Acta Toxicol. Ther. – ident: ref_8 doi: 10.1186/1471-2458-8-200 – volume: 21 start-page: 428 year: 2002 ident: ref_21 article-title: A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans publication-title: J. Am. Coll. Nutr. doi: 10.1080/07315724.2002.10719246 – ident: ref_22 doi: 10.20944/preprints201801.0046.v2 – volume: 41 start-page: 107 year: 2011 ident: ref_1 article-title: Diseases and disorders associated with excess body weight publication-title: Ann. Clin. Lab. Sci. – volume: 28 start-page: 1149 year: 2004 ident: ref_37 article-title: The effect of the dietary supplement, chitosan, on body weight: A randomised controlled trial in 250 overweight and obese adults publication-title: Int. J. Obes. doi: 10.1038/sj.ijo.0802693 – volume: 16 start-page: 215 year: 1995 ident: ref_55 article-title: Lipid-lowering effect of chitosan dietary integrator and hypocaloric diet in obese subjects [Effetto antilipemico dell’integratore dietetico Chitosano e della dieta ipocalorica in soggetti obesi] publication-title: Acta Toxicol. Ther. – volume: 385 start-page: 2326 year: 2015 ident: ref_12 article-title: Rethinking and reframing obesity publication-title: Lancet doi: 10.1016/S0140-6736(15)60163-5 – ident: ref_30 doi: 10.1186/s40608-015-0053-5 – volume: 6 start-page: 397 year: 2003 ident: ref_51 article-title: Improvement of HDL- and LDL-cholesterol levels in diabetic subjects by feeding bread containing chitosan publication-title: J. Med. Food doi: 10.1089/109662003772519985 – volume: 97 start-page: 4250 year: 2017 ident: ref_33 article-title: Effect of a polysaccharide-rich hydrolysate from Saccharomyces cerevisiae (LipiGo(R)) in body weight loss: Randomised, double-blind, placebo-controlled clinical trial in overweight and obese adults publication-title: J. Sci. Food Agric. doi: 10.1002/jsfa.8301 – volume: 5 start-page: 1218 year: 2013 ident: ref_3 article-title: Dyslipidemia in obesity: Mechanisms and potential targets publication-title: Nutrients doi: 10.3390/nu5041218 – ident: ref_27 doi: 10.2903/j.efsa.2011.2214 – volume: 30 start-page: 392 year: 2010 ident: ref_32 article-title: Chitosan improves insulin sensitivity as determined by the euglycemic-hyperinsulinemic clamp technique in obese subjects publication-title: Nutr. Res. doi: 10.1016/j.nutres.2010.06.005 – volume: 64 start-page: 248 year: 2003 ident: ref_40 article-title: Effects of a stimulant-free dietary supplement on body weight and fat loss in obese adults: A six-week exploratory study publication-title: Curr. Ther. Res. Clin. Exp. doi: 10.1016/S0011-393X(03)00058-4 – volume: 5 start-page: e002713 year: 2016 ident: ref_16 article-title: Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.115.002713 – volume: 53 start-page: 379 year: 1999 ident: ref_23 article-title: Randomized, double-blind trial of chitosan for body weight reduction publication-title: Eur. J. Clin. Nutr. doi: 10.1038/sj.ejcn.1600733 – volume: 23 start-page: 1703 year: 2000 ident: ref_52 article-title: Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia publication-title: Diabetes Care doi: 10.2337/diacare.23.11.1703a – volume: 289 start-page: 187 year: 2003 ident: ref_10 article-title: Years of life lost due to obesity publication-title: JAMA doi: 10.1001/jama.289.2.187 – volume: 4 start-page: 42 year: 2001 ident: ref_38 article-title: A Randomized, Double-Blind, Placebo Controlled Study Examining the Effects of a Rapidly Soluble Chitosan Dietary Supplement on Weight Loss and Body Composition in Overweight and Mildly Obese Individuals publication-title: J. Am. Nutraceutical Assoc. – volume: 187 start-page: 184 year: 2015 ident: ref_14 article-title: Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care publication-title: Can. Med. Assoc. J. doi: 10.1503/cmaj.140887 – volume: 6 start-page: 35 year: 2005 ident: ref_48 article-title: Effect of chitosan on weight loss in overweight and obese individuals: A systematic review of randomized controlled trials publication-title: Obes. Rev. doi: 10.1111/j.1467-789X.2005.00158.x – volume: 97 start-page: 98 year: 2005 ident: ref_24 article-title: Microcrystalline chitosan is ineffective to decrease plasma lipids in both apolipoprotein E epsilon 4 carriers and non-carriers: A long-term placebo-controlled trial in hypercholesterolaemic volunteers publication-title: Basic Clin. Pharmacol. Toxicol. doi: 10.1111/j.1742-7843.2005.pto_111.x – volume: 13 start-page: 1 year: 2009 ident: ref_11 article-title: The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: A systematic review and economic evaluation publication-title: Health Technol. Assess. doi: 10.3310/hta13410 – ident: ref_7 – volume: 15 start-page: 3 year: 2016 ident: ref_31 article-title: Single-blind, placebo controlled randomised clinical study of chitosan for body weight reduction publication-title: Nutr. J. doi: 10.1186/s12937-016-0122-8 – volume: 2 start-page: 29 year: 2012 ident: ref_6 article-title: The Combination of a High-protein Formula Diet and Polyglucosamine Decreases Body Weight and Parameters of Glucose and Lipid Metabolism in Overweight and Obese Men and Women publication-title: Eur. J. Food Res. Rev. – volume: 38 start-page: 603 year: 2007 ident: ref_18 article-title: Chitin and Chitosan—General Properties and Applications publication-title: Prog. Polym. Sci. – volume: 3 start-page: CD003892 year: 2008 ident: ref_34 article-title: Chitosan for overweight or obesity publication-title: Cochrane Database Syst. Rev. – volume: 5 start-page: 351 year: 1977 ident: ref_36 article-title: 9: Integrating Findings: The Meta-Analysis of Research publication-title: Rev. Res. Educ. – volume: 20 start-page: 614 year: 1997 ident: ref_49 article-title: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) publication-title: Diabetes Care doi: 10.2337/diacare.20.4.614 – ident: ref_20 doi: 10.1201/EBK1439816035 – volume: 11 start-page: 461 year: 1998 ident: ref_47 article-title: Chitosan as a treatment for body weight reduction: A meta-analysis publication-title: Perfusion – volume: 1 start-page: e000919 year: 2017 ident: ref_42 article-title: Long-Term Treatment of Overweight and Obesity with Polyglucosamine (PG L112): Randomized Study Compared with Placebo in Subjects after Caloric Restriction publication-title: Curr. Dev. Nutr. doi: 10.3945/cdn.117.000919 – volume: 42 start-page: 6 year: 2001 ident: ref_41 article-title: In the absence of dietary surveillance, chitosan does not reduce plasma lipids or obesity in hypercholesterolaemic obese Asian subjects publication-title: Singap. Med. J. – volume: 2 start-page: 165 year: 2002 ident: ref_50 article-title: Dysglycemia: A key cardiovascular risk factor publication-title: Semin. Vasc. Med. doi: 10.1055/s-2002-32040 – volume: 17 start-page: 301 year: 1996 ident: ref_54 article-title: A new approach to the treatment of obesity: Chitosan’s effects on body weight reduction and plasma cholesterol’s levels [Un nuovo approccio al trattamento dell’obesita: Effetti del chitosano sulla riduzione del peso corporeo e sulla colesterolemia] publication-title: Acta Toxicol. Ther. – volume: 17 start-page: 53 year: 1996 ident: ref_46 article-title: Effect of a new chitosan dietary integrator and hypocaloric diet on hyperlipidemia and overweight in obese patients publication-title: Acta Toxicol. Ther. – volume: 65 start-page: 563 year: 2017 ident: ref_25 article-title: Effect of NaCl + Chitosan 3% vs. NaCl on high blood pressure parameters of healthy volunteers with prehypertension publication-title: Miner. Cardioangiol. – volume: 25 start-page: 389 year: 2006 ident: ref_39 article-title: Evaluating efficacy of a chitosan product using a double-blinded, placebo-controlled protocol publication-title: J. Am. Coll. Nutr. doi: 10.1080/07315724.2006.10719550 – volume: 52 start-page: 1 year: 2002 ident: ref_28 article-title: Cholesterol-lowering properties and safety of chitosan publication-title: Arzneimittelforschung – ident: ref_43 – volume: 103 start-page: 418 year: 2005 ident: ref_53 article-title: Effect of chitosan on lipid levels when administered concurrently with atorvastatin--a placebo-controlled study publication-title: J. Indian Med. Assoc. – volume: 384 start-page: 766 year: 2014 ident: ref_13 article-title: Global, regional and national prevalence of overweight and obesity in children and adults 1980–2013: A systematic analysis publication-title: Lancet doi: 10.1016/S0140-6736(14)60460-8 – volume: 16 start-page: 199 year: 1995 ident: ref_45 article-title: Weight-reducing regimens in obese subjects: Effects of a new dietary fibre integrator publication-title: Acta Toxicol. Ther. – volume: 24 start-page: 87 year: 2012 ident: ref_2 article-title: Obesity as a risk factor for artherial hypertension publication-title: Mater. Socio-Med. doi: 10.5455/msm.2012.24.87-90 – ident: ref_35 doi: 10.1371/journal.pmed.1000097 – volume: 9 start-page: 431 year: 2015 ident: ref_15 article-title: Endoscopic Treatment for Obesity: New Emerging Technology Trends publication-title: Gut Liver doi: 10.5009/gnl15125 – volume: 9 start-page: 348 year: 2009 ident: ref_5 article-title: Treating diabetes and prediabetes by focusing on obesity management publication-title: Curr. Diabetes Rep. doi: 10.1007/s11892-009-0055-0 – volume: 56 start-page: 71 year: 2008 ident: ref_29 article-title: Use of polyglucosamine and physical activity to reduce body weight and dyslipidemia in moderately overweight subjects publication-title: Minerva Cardioangiol. |
| SSID | ssj0032572 |
| Score | 2.30163 |
| SecondaryResourceType | review_article |
| Snippet | Background and objectives: Erratic results have been published concerning the influence of the dietary supplement chitosan used as a complementary remedy to... Erratic results have been published concerning the influence of the dietary supplement chitosan used as a complementary remedy to decrease the body weight of... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 109 |
| SubjectTerms | blood pressure body weight chitosan meta-analysis overweight and obese patients Review serum lipids |
| Title | A Meta-Analysis on Randomised Controlled Clinical Trials Evaluating the Effect of the Dietary Supplement Chitosan on Weight Loss, Lipid Parameters and Blood Pressure |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30545156 https://www.proquest.com/docview/2157675848 https://pubmed.ncbi.nlm.nih.gov/PMC6306953 https://doaj.org/article/d96736d416b24fd59e2eb8456c0aac2c |
| Volume | 54 |
| WOSCitedRecordID | wos000455621300018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1648-9144 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032572 issn: 1648-9144 databaseCode: DOA dateStart: 20070101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1648-9144 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032572 issn: 1648-9144 databaseCode: 7X7 dateStart: 20180101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1648-9144 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032572 issn: 1648-9144 databaseCode: BENPR dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1648-9144 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032572 issn: 1648-9144 databaseCode: PIMPY dateStart: 20180101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZgQYgL4k14VEbigkTU1Eka-7gtXYFEq2i1iHKK7LHDVlo5qO0i8YP4n8zYabVdIbhwifJwYiczsb_xjL9h7I3WzlpweSqlLlPEty6VbgSpyk1ZGUSwuclCsolqsZDLpaqvpPqimLBIDxw_3NAqijyyiBuMKFpbKieckTjsQ6Y1CKDeF1HPzpiKfXCOiiiiUzJHo37Y-6k1whMyQNTBIBS4-v8EMK_HSV4ZeE7us3s9YuTHsaUP2A3nH7I7894n_oj9OuZzt9Xpjl6Ed56fam87lKCzfBpj0S9ot18Fyc-C1vFZz_Ttv3GEgTwSGfOuDUfvV_jQ9U8e0n6GOUQ-Pcfff6M91fAlTKnyT_h67zglwLa81hToRWydHKvnEwqJ53H54do9Zp9PZmfTD2mffCGFYiy2Kcgc3FhqQ75XW7bQGkBbzJIUIJPOGmczyDJdjFRrXVWitevKQlSghRVg8yfsyHfePWPcCFOi4MAoqApQzhjirWqhIG7nSkHChjtpNNAzk1OCjIsGLRSSX3Ndfgl7u7_je2Tl-EvZCQl4X474tMMJ1LKm17LmX1qWsNc79WhQeuRU0d51l5sGIRPx4chCJuxpVJd9VdiXFogXxwmrDhTpoC2HV_zqPHB8j9GUU2X-_H80_gW7izBPUhDOSLxkR9v1pXvFbsOP7WqzHrCb1bIKWzlgtyazRX06CD8THtUf5_XX37sWKjg |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Meta-Analysis+on+Randomised+Controlled+Clinical+Trials+Evaluating+the+Effect+of+the+Dietary+Supplement+Chitosan+on+Weight+Loss%2C+Lipid+Parameters+and+Blood+Pressure&rft.jtitle=Medicina+%28Kaunas%2C+Lithuania%29&rft.au=Moraru%2C+Cristina&rft.au=Mincea%2C+Manuela+Maria&rft.au=Frandes%2C+Mirela&rft.au=Timar%2C+Bogdan&rft.date=2018-12-12&rft.issn=1648-9144&rft.eissn=1648-9144&rft.volume=54&rft.issue=6&rft_id=info:doi/10.3390%2Fmedicina54060109&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1648-9144&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1648-9144&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1648-9144&client=summon |